NCT05376930View on ClinicalTrials.gov

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
T2DM (Type 2 Diabetes Mellitus)
Interventions
DRUG

DWP16001 Amg

DWP16001 Amg, Tablets, Orally, Once daily

Trial Locations (1)

Unknown

Daewoong pharmatceutical, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT05376930 - Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. | Biotech Hunter | Biotech Hunter